Psoralidin: emerging biological activities of therapeutic benefits and its potential utility in cervical cancer

Cervical cancer (CaCx) is the fourth most prevalent cancer in women contributing to 341,831 annual deaths globally in 2020. Owing to its high mortality rate, the identification of novel inhibitors preventing CaCx progression is of utmost importance. Recent studies have emphasized the use of phytoche...

Full description

Saved in:
Bibliographic Details
Main Authors: Tanya Tripathi, Apoorva Chaudhary, Divya Janjua, Udit Joshi, Nikita Aggarwal, Chetkar Chandra Keshavam, Alok Chandra Bharti
Format: Article
Language:English
Published: Open Exploration 2024-09-01
Series:Exploration of Drug Science
Subjects:
Online Access:https://www.explorationpub.com/uploads/Article/A100863/100863.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!